Characteristics, Impact and Antimicrobial Treatment of Bacterial and Fungal Infections in the COVID-19 Era
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: closed (15 July 2023) | Viewed by 3763
Special Issue Editors
Interests: clinical microbiology; implant-associated infection; mycobacterial infection; HIV; tuberculosis; gram-positive bacterial infections
Interests: clinical microbiology; difficult-to-treat infections; multidrug-resistant infections; implant-associated infection; viral infections; Mycobacterial infection
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In contrast to the lower frequency of community-acquired bacterial co-infection, secondary bacterial infections among COVID-19 patients have been reported with a prevalence as high as 50%, with the highest rate observed in intensive care units. These infections are often caused by multidrug-resistant pathogens—including carbapenem-resistant Gram-negative bacteria (42% in a recent meta-analysis)—and associated with a high mortality rate (30-55%). Invasive fungal secondary infections, such as Aspergillus spp. and Candida auris, have also been reported in COVID-19 wards, and these are associated to nosocomial outbreaks and high mortality.
This Special Issue aims to update and highlight the features and burden of bacterial and fungal infections among patients infected by SARS-CoV-2, their impact with respect to clinical outcome, organizational and financial resources, as well as the correct diagnostic and therapeutic approach, with a focus on multidrug-resistant and other difficult-to-treat infections, including: methicillin-resistant S. aureus, Vancomycin-resistant Enterococcus spp., Carbapenem-resistant Enterobacterales, difficult-to-treat Pseudomonas aeruginosa, extensively-resistant Acinetobacter baumannii, Clostridioides difficile, Aspergillus spp., and Candida auris.
Dr. Sergio Carbonara
Dr. Davide Fiore Bavaro
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- SARS-CoV-2
- COVID-19
- bacterial infections
- invasive fungal infections
- multi-drug resistance
- Acinetobacter baumannii
- methicillin-resistant S. aureus
- Vancomycin-resistant Enterococcus spp.
- Carbapenem-resistant Enterobacterales
- difficult to treat Pseudomonas aeruginosa
- extensively-resistant Acinetobacter baumannii
- Clostridioides difficile
- Aspergillus spp.
- Candida auris
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.